LATEST NEWS

Relief Therapeutics and NeuroRx Announce Final Manufacturing Validation of RLF-100 for Phase 2b/3 Clinical Trial in Patients with
COVID-19 Associated Acute Respiratory Distress Syndrome

LATEST NEWS

UCI to take part in clinical trial of drug for critically ill COVID-19 patients
Aviptadil could save people suffering from acute respiratory distress syndrome

Contact Us

Phone: (714) 455-1300

Email: info@medisourcerx.com

Fax: (714) 455-1395

Hours of Operation

Monday through Friday

7:30am-4:00pm PST